ARIZONA HOUSE OF REPRESENTATIVES

Fifty-third Legislature - Second Regular Session

MAJORITY CAUCUS CALENDAR #10

March 20, 2018

BLUE SHEET #2 (concur/refuse)

Bill NumberShort TitleCommitteeDateAction

Committee on Banking and Insurance

Chairman:John M. Allen, LD15Vice Chairman:Eddie Farnsworth, LD12

Analyst:Paul BennyIntern:Lauren Kinzle

SB 1100workers' compensation; claim settlement

SPONSOR:FANN, LD1

SENATE2/20/2018(30-0-0-0)

BI3/5DPA(7-1-0-0-0)

(No: POWERS HANNLEY)

SB 1101property tax appeals; court findings

(BI S/E: captive insurers; licensing)

SPONSOR:PETERSEN, LD12

SENATE2/8/2018(18-12-0-0)

(No: DALESSANDRO,CAJERO BEDFORD,OTONDO,PESHLAKAI,FARLEY,BRADLEY,CONTRERAS,HOBBS,MENDEZ,MIRANDA,QUEZADA,MEZA)

BI3/12DPA/SE(5-3-0-0-0)

(No: POWERS HANNLEY,SALMAN,BUTLER)

SB 1111workers' compensation; opioids; dispensed medications

SPONSOR:FANN, LD1

SENATE2/27/2018(28-2-0-0)

(No: PETERSEN,BARTO)

BI3/12DP(7-1-0-0-0)

(No: FARNSWORTH E)

SB 1217insurance; small employers; continuation coverage

SPONSOR:BROPHY MCGEE, LD28

SENATE2/22/2018(30-0-0-0)

BI3/12DP(7-1-0-0-0)

(No: MOSLEY)

SB 1381service contracts

SPONSOR:PETERSEN, LD12

SENATE2/26/2018(29-0-1-0)

(NV: BURGES)

BI3/12DP(5-3-0-0-0)

(No: POWERS HANNLEY,SALMAN,BUTLER)

Committee on Commerce

Chairman:Jeff Weninger, LD17Vice Chairman:Jill Norgaard, LD18

Analyst:Diana ClayIntern:Josefina Torres

SB 1117liquor establishments; peace officers; firearms

SPONSOR:KAVANAGH, LD23

SENATE2/8/2018(17-13-0-0)

(No: DALESSANDRO,CAJERO BEDFORD,OTONDO,PESHLAKAI,FARLEY,BRADLEY,BOWIE,CONTRERAS,HOBBS,MENDEZ,MIRANDA,QUEZADA,MEZA)

COM3/13DP(6-3-0-0-0)

(No: ESPINOZA,EPSTEIN,CHÁVEZ)

SB 1199drug testing; eye movement analysis

SPONSOR:WORSLEY, LD25

SENATE2/8/2018(30-0-0-0)

COM3/13DP(9-0-0-0-0)

SB 1264bank deposits; technical correction

(Now: gift cards; dormancy fee; prohibition)

SPONSOR:YARBROUGH, LD17

SENATE2/26/2018(29-0-1-0)

(NV: BURGES)

COM3/13DPA(9-0-0-0-0)

SB 1443certified public accountants

SPONSOR:YEE, LD20

SENATE2/27/2018(30-0-0-0)

COM3/13DP(9-0-0-0-0)

SB 1499community facilities districts; directors

SPONSOR:SMITH, LD11

SENATE2/22/2018(30-0-0-0)

COM3/13DP(9-0-0-0-0)

SB 1500employment security; employee; employer; status

SPONSOR:SMITH, LD11

SENATE2/22/2018(19-11-0-0)

(No: DALESSANDRO,OTONDO,PESHLAKAI,FARLEY,BOWIE,CONTRERAS,HOBBS,MENDEZ,MIRANDA,QUEZADA,MEZA)

COM3/6DP(4-3-0-2-0)

(No: ESPINOZA,EPSTEIN,CHÁVEZ; Abs: NORGAARD,SYMS)

Committee on Education

Chairman:Paul Boyer, LD20Vice Chairman:Douglas Coleman, LD16

Analyst:Aaron WondersIntern:Ileen Younan

SB 1291schools; pupil assessment data

SPONSOR:BROPHY MCGEE, LD28

SENATE3/5/2018(29-0-1-0)

(NV: BURGES)

ED3/12DPA(9-0-0-1-0)

(Abs: STRINGER)

SB 1422universities; tuition and fees

SPONSOR:GRIFFIN, LD14

SENATE2/28/2018(30-0-0-0)

ED3/12DP(8-0-1-1-0)

(Abs: STRINGER; Present: BOLDING)

Committee on Energy, Environment and Natural Resources

Chairman:Russell "Rusty" Bowers, LD25Vice Chairman:Brenda Barton, LD6

Analyst:Sharon CarpenterIntern:Adrienne Austill

SB 1253game and fish; licenses; fees.

SPONSOR:GRIFFIN, LD14

SENATE2/13/2018(27-2-1-0)

(No: PETERSEN,FARNSWORTH D; NV: HOBBS)

EENR3/13DP(8-0-0-2-0)

(Abs: GONZALES,LEACH)

SB 1508water; desalination action plan

SPONSOR:GRIFFIN, LD14

SENATE2/22/2018(30-0-0-0)

EENR3/13DP(9-0-0-1-0)

(Abs: LEACH)

SB 1510irrigation grandfathered right; containerized plants

SPONSOR:GRIFFIN, LD14

SENATE2/22/2018(20-10-0-0)

(No: DALESSANDRO,CAJERO BEDFORD,PESHLAKAI,FARLEY,BRADLEY,CONTRERAS,HOBBS,MENDEZ,QUEZADA,MEZA)

EENR3/13DP(8-1-0-1-0)

(No: GONZALES; Abs: LEACH)

SB 1511Pinal AMA; groundwater; extinguishment credits

SPONSOR:GRIFFIN, LD14

SENATE2/22/2018(17-13-0-0)

(No: DALESSANDRO,CAJERO BEDFORD,OTONDO,PESHLAKAI,FARLEY,BRADLEY,BOWIE,CONTRERAS,HOBBS,MENDEZ,MIRANDA,QUEZADA,MEZA)

EENR3/13DP(7-2-0-1-0)

(No: GONZALES,DESCHEENIE; Abs: LEACH)

SCR 1031water management; sources; policies; support

(EENR S/E: support; water management policies)

SPONSOR:GRIFFIN, LD14

SENATE2/22/2018(30-0-0-0)

EENR3/13DPA/SE(9-0-0-1-0)

(Abs: LEACH)

Committee on Government

Chairman:Douglas Coleman, LD16Vice Chairman:Bob Thorpe, LD6

Analyst:Michael HansIntern:Stiv Fico

SB 1274public monies; recovery; illegal payments

SPONSOR:PETERSEN, LD12

SENATE2/21/2018(30-0-0-0)

GOV3/15DPA(7-0-0-1-0)

(Abs: JOHN)

Committee on Health

Chairman:Heather Carter, LD15Vice Chairman:Regina E. Cobb, LD5

Analyst:Rick HazeltonIntern:Tyler Stephens

SB 1166permanent guardianship; subsidy

SPONSOR:BROPHY MCGEE, LD28

SENATE2/27/2018(30-0-0-0)

HEALTH3/15DP(8-0-0-1-0)

(Abs: SYMS)

SB 1380children; out-of-home placement

SPONSOR:PETERSEN, LD12

SENATE2/28/2018(30-0-0-0)

HEALTH3/15DPA(8-0-0-1-0)

(Abs: SYMS)

SB 1397behavioral health; dependent children; reports

SPONSOR:BARTO, LD15

SENATE2/27/2018(30-0-0-0)

HEALTH3/15DP(8-0-0-1-0)

(Abs: SYMS)

SB 1473schools; civics literacy state seal

(HEALTH S/E: kinship care; aggravated circumstances; dependency)

SPONSOR:BARTO, LD15

SENATE2/28/2018(17-13-0-0)

(No: DALESSANDRO,CAJERO BEDFORD,OTONDO,PESHLAKAI,FARLEY,BRADLEY,BOWIE,CONTRERAS,HOBBS,MENDEZ,MIRANDA,QUEZADA,MEZA)

HEALTH3/15DPA/SE(9-0-0-0-0)

SB 1518department of child safety; reports

SPONSOR:BROPHY MCGEE, LD28

SENATE2/27/2018(30-0-0-0)

HEALTH3/15DP(8-0-0-1-0)

(Abs: SYMS)

Committee on Judiciary and Public Safety

Chairman:Eddie Farnsworth, LD12Vice Chairman:Anthony T. Kern, LD20

Analyst:Katy ProctorIntern:Samantha Cox

SB 1071adoption; subsidy; review; nonrecurring expenses

SPONSOR:BROPHY MCGEE, LD28

SENATE2/8/2018(30-0-0-0)

JPS2/28DP(9-0-0-0-0)

APPROP3/14DP(8-0-0-5-0)

(Abs: BOWERS,CARTER,LEACH,RIVERO,UGENTI-RITA)

SB 1394DHS; reporting; abortions

SPONSOR:BARTO, LD15

SENATE2/22/2018(17-13-0-0)

(No: DALESSANDRO,CAJERO BEDFORD,OTONDO,PESHLAKAI,FARLEY,BRADLEY,BOWIE,CONTRERAS,HOBBS,MENDEZ,BROPHY MCGEE,QUEZADA,MEZA)

JPS3/14DPA(6-3-0-0-0)

(No: GONZALES,HERNANDEZ,ENGEL)

SB 1395temporary custody without court order

SPONSOR:BARTO, LD15

SENATE3/1/2018(24-6-0-0)

(No: ALLEN S,SMITH,PETERSEN,GRIFFIN,FARNSWORTH D,BURGES)

JPS3/14DPA(8-1-0-0-0)

(No: KERN)

Committee on Land, Agriculture and Rural Affairs

Chairman:Brenda Barton, LD6Vice Chairman:Darin Mitchell, LD13

Analyst:Sharon CarpenterIntern:Adrienne Austill

SB 1379flood protection districts; divisions; electors

SPONSOR:PRATT, LD8

SENATE2/21/2018(30-0-0-0)

LARA3/15DPA(9-0-0-0-0)

Committee on Local and International Affairs

Chairman:Tony Rivero, LD21Vice Chairman:Todd A. Clodfelter, LD10

Analyst:Michael HansIntern:Stiv Fico

SB 1201county treasurer; electronic records; liens

SPONSOR:WORSLEY, LD25

SENATE2/20/2018(30-0-0-0)

LIA3/14DP(7-0-0-0-0)

SB 1247health insurance; mandated provision prohibited

SPONSOR:BARTO, LD15

SENATE2/5/2018(17-13-0-0)

(No: DALESSANDRO,CAJERO BEDFORD,OTONDO,PESHLAKAI,FARLEY,BRADLEY,BOWIE,CONTRERAS,HOBBS,MENDEZ,MIRANDA,QUEZADA,MEZA)

LIA3/14DP(4-3-0-0-0)

(No: GABALDÓN,BLANC,CHÁVEZ)

Committee on Military, Veterans and Regulatory Affairs

Chairman:Jay Lawrence, LD23Vice Chairman:Mark Finchem, LD11

Analyst:Brittany GreenIntern:Amanda Higby

SB 1431memorial; veterans; suicide

SPONSOR:BARTO, LD15

SENATE2/21/2018(30-0-0-0)

MVRA3/5DP(7-2-0-0-0)

(No: FINCHEM,DESCHEENIE)

SB 1496prisoners; drug sentences; out-of-custody treatment

SPONSOR:SMITH, LD11

SENATE2/27/2018(30-0-0-0)

MVRA3/12DP(8-0-0-1-0)

(Abs: DESCHEENIE)

APPROP3/14DP(9-0-0-4-0)

(Abs: BOWERS,CARTER,LEACH,RIVERO)

Committee on Transportation and Infrastructure

Chairman:Noel W. Campbell, LD1Vice Chairman:Drew John, LD14

Analyst:Liam MaherIntern:Samuel Rosenberg

SB 1401ignition interlock device; installer; manufacturer

SPONSOR:WORSLEY, LD25

SENATE2/15/2018(29-0-1-0)

(NV: MIRANDA)

TI3/7DP(7-0-0-1-0)

(Abs: SALDATE)

SB 1502ignition interlock device; incarceration credits

SPONSOR:SMITH, LD11

SENATE3/1/2018(29-1-0-0)

(No: MIRANDA)

TI3/14DP(8-0-0-0-0)

Committee on Ways and Means

Chairman:Michelle B. Ugenti-Rita, LD23Vice Chairman:Vince Leach, LD11

Analyst:Michael MaddenIntern:Elizabeth Lange

SB 1405corporate income tax allocation; sales

SPONSOR:FANN, LD1

SENATE2/22/2018(30-0-0-0)

WM3/14DP(7-0-0-2-0)

(Abs: BOLDING,CARDENAS)

SB 1467STOs; corporations; caps; scholarship eligibility

SPONSOR:YARBROUGH, LD17

SENATE2/28/2018(16-14-0-0)

(No: DALESSANDRO,CAJERO BEDFORD,OTONDO,PESHLAKAI,FARLEY,BRADLEY,BOWIE,CONTRERAS,HOBBS,MENDEZ,MIRANDA,BROPHY MCGEE,QUEZADA,MEZA)

WM3/14DP(6-3-0-0-0)

(No: BOLDING,CARDENAS,EPSTEIN)

SCR 1007senior property valuation freeze; income

SPONSOR:GRIFFIN, LD14

SENATE2/1/2018(28-0-2-0)

(NV: PESHLAKAI,YEE)

WM3/14DP(7-0-0-2-0)

(Abs: BOLDING,CARDENAS)

Page 1 of 67

ARIZONA HOUSE OF REPRESENTATIVES

Fifty-third LegislatureSB 1100

Second Regular SessionVersion 2: Caucus & COW

SB 1100:workers' compensation; claim settlement
PRIME SPONSOR: Senator Fann, LD 1
BILL STATUS:Caucus & COW
/

Abstract

Relating to settlement of workers' compensation claims.

Provisions

Full and Final Settlements (Sec. 1)

  1. Clarifies that an interested party to a claim can negotiate a settlement of an accepted claim if the period of temporary disability is terminated by a final notice of claim status, award of the ICA or stipulation of the interested parties.
  2. Allows an authorized representative of a carrier, special fund or self-insured employer to sign a settlement.
  3. Requires a settlement to have attached certain information provided by a carrier, special fund or self-insured employer.
  4. Requires settlements to include specified signed attestations regardless if the employee is represented by counsel.
  5. Adds the following attestations that must be included in a settlement:
  6. The settlement amount representing future medical, surgical and hospital benefits;
  7. The present value and total amount of future indemnity benefits;
  8. The employee's life expectancy and rated age if applicable;
  9. The source of the employee's life expectancy;
  10. The discount rate used to calculate the present value and total amount of future indemnity benefits;
  11. The parties have conducted a search for and taken responsible steps to satisfy any unpaid medical charges; and
  12. The settlement was not achieved through coercion, duress, fraud, misrepresentation or undisclosed additional agreements.
  13. Removes the authorization for an ALJ to approve the settlement.
  14. ADDS THE REQUIREMENT FOR AN ALJ TO APPROVE THE SETTLEMENT IF THE EMPLOYEE IS REPRESENTED BY COUNSEL AND CERTAIN REQUIREMENTS ARE MET. (BI)
  15. Directs an ALJ, if an employee is without counsel, to conduct a hearing and perform a detailed inquiry into the employee's attestations. The inquiry must include:
  16. Whether the employee understands the specific right being settled and released;
  17. The information, computation and methodology provided by the carrier, special fund or self-insured employer; and
  18. The employee's responsibility to protect the interest of other payors and ensure the payment of future treatment costs.
  19. Eliminates the requirement when approving a settlement that the ICA consider whether it is in the best interest of the employee based on specified criteria.
  20. Permits the ICA to approve a settlement if certain requirements are met.

Supportive Medical Maintenance Benefits (Sec. 2)

  1. States that any final settlement agreement involving undisputed entitlement to supportive medical maintenance benefits is not valid and enforceable until approved by the ICA.
  2. Permits the ICA to approve a final settlement agreement involving undisputed entitlement to supportive medical maintenance benefits if certain requirements are satisfied.
  3. Allows interested parties to a claim to enter into a final settlement and release of a claim for undisputed entitlement to supportive medical maintenance benefits after the period of temporary disability is terminated by a final notice of claim status or award of the ICA.
  4. Directs a carrier, special fund or self-insured employer to submit a summary of all reasonably anticipated future supportive medical maintenance benefitsand the projected cost of the benefits for review by the employee.
  5. Requires the summary to be included with the final statement agreement filed with the ICA.
  6. Requires all medical conditions subject to the final settlement agreement to be described in the agreement.
  7. Requires the final settlement provisions only apply to future supportive medical maintenance benefits for the described condition.
  8. Directs a carrier, special fund or self-insured employer to inform the attending physician of the approval of a final settlement agreement.
  9. Directs a carrier, special fund or self-insured employer to remain responsible for payment for the treatment not covered by the final agreement unless supportive medical maintenance benefits rendered before the date of the final settlement are disputed or payment for treatment was included.
  10. Asserts the requirements for a final settlement do not prohibit any other settlement.
  11. Defines final settlement.

Miscellaneous (Sec. 1)

  1. Makes technical and conforming changes.

Current Law

A.R.S. § 23-941.01 governs the approval of a full and final settlement of an employee's workers' compensation claim by the ICA. A full and final settlement is not considered valid and enforceable unless it is approved by the ICA. When determining if a settlement should be approved, the ICA must consider whether the settlement is in the best interests of the employee based on: 1) whether the employee's injuries are stabilized; and 2) the permanency of the employee's injuries.

Interested parties to a claim may: 1) settle and release an accepted claim for compensation, benefits, penalties or interest; and 2) negotiate a full and final settlement if the period of disability is terminated by the carrier, special fund or self-insured employer. A full and final settlement must: 1) be in writing; 2) be signed by the carrier, special fund or self-insured employer and the employee or the employee's authorized representative; 3) acknowledge that the employee had the opportunity to seek legal advice and be represented by counsel; and 4) include a description of the employee's medical conditions that have been identified and contemplated at the time of the settlement.

If an employee is represented by counsel, the full and final settlement must contain the following attestations: 1) the employee understands the rights settled and released; 2) the employee has been provided information from the carrier, special fund or self-insured employer that outlines any reasonable anticipated future benefits relating to the claim, the projected cost of those benefits and an explanation of how those projected costs were determined; 3) the employee understands that monies received for future medical treatment associated with the industrial injury should be set aside to ensure that the costs of treatment will be paid; 4) the parties have considered and taken reasonable steps to protect any interests of Medicare, Medicaid, the Indian Health Service and the US Department of Veterans Affairs; and 5) the parties have conducted a search for and taken reasonable steps to satisfy any identified medical liens.

If an employee is not represented by counsel, the employee must appear before an ALJ who is required to make specific factual findings regarding whether the statutory requirements are satisfied. The ALJ is prohibited from approving a settlement if it does not meet statutory requirements or is not deemed fair and reasonable to the employee.

Full and final settlement means a settlement in which the injured employee or, if the injured employee is deceased, the employee's estate, surviving spouse or dependent waives any future entitlement to benefits on the claim and any future right to change or reopen the claim.

Fifty-third LegislatureSB 1100

Second Regular SessionVersion 2: Caucus & COW

ARIZONA HOUSE OF REPRESENTATIVES

Fifty-third LegislatureSB 1101

Second Regular SessionVersion 2: Caucus & COW

SB 1101:S/E: captive insurers; licensing
PRIME SPONSOR: Senator Petersen, LD 12
BILL STATUS:Caucus & COW
WM: W/D 0-0-0-0
BI: DPA/SE 5-3-0-0
/

Abstract

Relating to agency captive insurers and insurance risks.

Provisions

  1. Allows an agency captive insurer to directly insure life or disability insurance risks with the approval of the Director. (Sec. 1)

Current Law

An agency captive insurer insures risks on policies placed through its owners and is owned by one or more business entities which are state-licensed as insurance producers or managing general agents (A.R.S. § 20-1098). An agency captive insurer is prohibited from insuring risks not placed by or through its owners and directly insuring life or disability insurance risks (A.R.S. § 20-1098.01).

Pursuant to A.R.S. § 20-508, an insurer, for disability insurance policies, must maintain an active life reserve which must place a sound value on its liabilities under the policy and be not less than the amounts that are necessary to assure payment of its policyholder obligations including reserves for unearned premiums.

The Director may require an insurer to compute the reserve if it is determined that an insurer's unearned premium reserve is inadequate (A.R.S. 20-509).

Fifty-third LegislatureSB 1101

Second Regular SessionVersion 2: Caucus & COW

ARIZONA HOUSE OF REPRESENTATIVES

Fifty-third LegislatureSB 1111

Second Regular SessionVersion 2: Caucus & COW

SB 1111:workers' compensation; opioids; dispensed medications
PRIME SPONSOR: Senator Fann, LD 1
BILL STATUS:Caucus & COW
BI: DP 7-1-0-0
/

Abstract

Relating to workers' compensation.

Provisions

  1. Requires a physician who prescribes a schedule II controlled substance to an employee to comply with statutory requirements relating to controlled substances.
  2. Laws 2018, First Special Session Chapter 1, provides for the requirements relating to controlled substances and becomes effective April 26, 2018. (Sec. 2)
  3. Modifies the information a physician must include in an ICA report as follows:
  4. Requires the report to contain information regarding the use of a schedule II narcotic or opium-based controlled substance and prescription of any opioid medication.
  5. The report must further include the following:
  6. Documentation regarding a physical examination, substance use risk assessment, and informed consent from the employee for opioid treatment.
  7. The frequency of face-to-face follow up visits to reevaluate an employee's continued use of opioids, guidelines for tapering and discontinuing the opioid, and the offering of treatment for opioid dependency or addiction associated with a treatment plan. (Sec. 2)
  8. Removes the provision regarding writing or dispensing an initial prescription order. (Sec. 2)
  9. Requires a physician to obtain an employee's CSPMP utilization report prior to prescribing the employee an opioid analgesic or benzodiazepine controlled substance that is listed as schedule II, III, or IV.
  10. A physician must obtain a report at least quarterly while that prescription remains part of the treatment. (Sec. 2)
  11. Allows the insurance carrier, self-insured employer or ICA to request, not more than once every two months, that a physician obtain a CSPMP utilization report regarding an employee. (Sec. 2)
  12. Clarifies the CSPMP utilization report, rather than the results of an inquiry to the Arizona State Board of Pharmacy is used to determine if the employee is receiving opioids from another provider. (Sec. 2)
  13. Asserts that the insurance carrier or self-insured employer is not liable for any action reasonably necessary to monitor or assess the appropriateness and effectiveness of the employee's opioid use. (Sec. 2)
  14. Allows the ICA to adopt fee reimbursement guidelines for medications dispensed in settings not accessible to the public. (Sec. 1)
  15. Requires the ICA to review the fee reimbursement guidelines with stakeholders and hold a public hearing by July 1, 2019.
  16. Repeals this requirement on July 1, 2020. (Sec. 3)
  17. Removes the qualification that a physician practice pain management in a change of physician ordered by the ICA. (Sec. 2)
  18. Removes the reporting exemption for medications administered to the employee while receiving inpatient hospital treatment. (Sec. 2)
  19. Modifies the definition of clinically meaningful improvement in function as:
  20. A significant improvement in the performance of daily activities or reduction in work restrictions; and
  21. A reduction in dependency on continued medical treatment. (Sec. 2)
  22. Eliminates the definition of off-label use. (Sec. 2)
  23. Defines substance use risk assessment as an evaluation of an employee's likelihood for opioid addiction, misuse, diversion or another adverse consequence. (Sec. 2)
  24. Defines a traumatic injury as a physical injury that creates a reasonable risk of death or that causes serious or permanent impairment. (Sec. 2)
  25. Makes technical and conforming changes. (Sec. 1-3)

Current Law

A.R.S. Title 23, Chapter 6 outlines the scope, administration and process of compensation for workers’ compensation insurance. The ICA regulates the worker's compensation system to ensure that any claim is processed in accordance with statues and rules. The ICA produces a schedule of fees to be charged by a physician treating an injured employee. A physician must report to the ICA documentation pertaining to the off-label use, use of and prescription of a narcotic or opium-based controlled substance.

Laws 2018, First Special Session, Chapter 1 limits all initial prescriptions for opioids to a 5-day supply and prescriptions for opioids following surgical procedures to a 14-day supply, with certain exceptions. The legislation also provides dosage limits for opioids, with exception.

A.R.S. § 36-2606 provides that each medical practitioner and pharmacist must have a current CSPMP registration and be granted access to the program’s central database tracking system.

A.R.S § 36-2513 defines schedule II controlled substance as any material, compound, mixture or preparation containing any quantity of the substances outlined in statute.

Fifty-third LegislatureSB 1111

Second Regular SessionVersion 2: Caucus & COW

ARIZONA HOUSE OF REPRESENTATIVES

Fifty-third LegislatureSB 1217

Second Regular SessionVersion 2: Caucus & COW

SB 1217:insurance; small employers; continuation coverage
PRIME SPONSOR: Senator Brophy McGee, LD 28
BILL STATUS:Caucus & COW
BI: DP 7-1-0-0
/

Abstract

Relating to small employer continuation coverage.